Nuvasive Stock News

UBS Asset Management Americas Inc. raised its position in NuVasive, Inc. (NASDAQ:NUVA) by 2.3% during the second quarter, Holdings Channel reports. The firm owned 58,635 shares of the medical device companys stock after buying an additional 1,326 shares during the quarter. UBS Asset Management Americas Inc.s holdings in NuVasive were worth $3,974,000 at the end []

NuVasive, Inc. (NASDAQ:NUVA) Research analysts at Piper Sandler reduced their FY2021 EPS estimates for NuVasive in a research note issued to investors on Wednesday, November 10th. Piper Sandler analyst M. Obrien now forecasts that the medical device company will earn $1.77 per share for the year, down from their previous estimate of $2.19. Piper []

Wall Street brokerages forecast that NuVasive, Inc. (NASDAQ:NUVA) will report earnings of $0.48 per share for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for NuVasives earnings, with the lowest EPS estimate coming in at $0.43 and the highest estimate coming in at $0.52. NuVasive reported earnings per share of $0.59 []

NuVasive (NASDAQ:NUVA) had its target price decreased by UBS Group from $59.00 to $54.00 in a research report released on Wednesday morning, Price Targets.com reports. UBS Group currently has a sell rating on the medical device companys stock. Other research analysts have also issued research reports about the stock. Loop Capital started coverage on shares []

NuVasive (NUVA) reported lower-than-expected earnings and revenues with COVID-led headwinds and healthcare staffing shortages dampening the Q3 top-line growth.

NuVasive Inc (NASDAQ: NUVA) reported Q3 net sales of $270.8 million, an 8.3% decrease on a reported and constant currency basis, missing the consensus of $291.79 million. "The third quarter presente

NuVasive, Inc. (NUVA) CEO Christopher Barry on Q3 2021 Results - Earnings Call Transcript

NuVasive (NUVA) delivered earnings and revenue surprises of -40.74% and -7.03%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

NuVasive (NASDAQ:NUVA) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement.

SAN DIEGO, Oct. 14, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integr

NuVasive's (NUVA) East Coast Experience Center reflects the company's commitment to provide best quality surgeon education and training to enhance the standard of patient care in spine surgery.

OrthoPediatrics (KIDS), Orthofix (OFIX), Zimmer Biomet (ZBH), Stryker (SYK) and SeaSpine (SPNE) are expected to hold ground despite a challenging business climate.

SAN DIEGO, Sept. 23, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integr

SAN DIEGO, Sept. 22, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integr

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.